Curr. Oncol., Volume 31, Issue 6 (June 2024) – 45 articles
Cover Story (view full-size image):
Hepatic artery embolization (HAE) is a well-established treatment for primary and secondary hepatic malignancies. The pattern of retained contrast on immediate post-procedure CT and cone-beam CT (CBCT) after HAE has been used to document the completion of treatment and predict treatment response. Visual or subjective evaluation of the post-treatment CT or CBCT is the most popular method. However, these methods are non-automated, solely dependent on the reviewer’s assessment, and not precise when evaluating tumors with inhomogeneous uptake. Therefore, there is a need to explore other objective imaging markers. This study aimed to examine the value of automated tumor enhancement parameters on CBCT obtained before and immediately after HAE in predicting treatment response, local progression-free survival, and overall survival. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Previous Issue
Next Issue
